Thursday, 5 February 2026
  
Login

Australia's most trusted
source of pharma news

Thursday, 5 February 2026
Vivacity
Vivacity
Local exec scores Aussie GM role

An experienced pharma executive who's held top roles at Lilly and Novartis has been named industry's newest Country Leader, appointed at a pivotal time for the company.

Aussie Open lifts pharma's game
Gruelling match between two tennis greats holds an important lesson for pharma, according to a former ANZ GM
TODAY
Fake meds trigger TGA safety alert
Laboratory testing finds "significant discrepancies" in the labelled content with the Regulator warning of accidental overdose
TODAY
Boss lands new Country Head role
Ex-MD scores top new role and she's not alone with widespread movement across industry in the latest employment moves
4 February
17 pharmas hunting expansions
Find out which new indications are on the cards after the TGA accepted a bumper list of applications late last year
4 February
Restructure hits Aussie workforce
Business structure review hits the Australian team as company 'reshapes and redefines some employee roles'
3 February
$200M PBS market slashed in half
The government has cut the PBS list price of a major drug, following negotiations with the sponsor
3 February
HPG
HPG
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (16)

Access & Reimbursement (1)

Clinical & Medical, R&D (7)

Regulatory, Pharmacovigilance & QA (5)

Executive Roles (4)

Other (21)

Patients slip through the cracks
National survey released to mark World Cancer Day today reveals critical gaps in cancer support for patients across Australia
4 February
Even better than semaglutide...
Novo may have outdone itself with a hyped combo outperforming its star T2 diabetes and obesity treatment in a head-to-head trial
4 February
Aussies drive brain cancer drug
Canadian company partners with local researchers and oncologists for a world-first clinical trial in children and adolescents
4 February
Aussies win global pharma grant
Selected from a tough field of more than 80 worldwide submissions, this joint initiative by two high-profile patient groups impressed
3 February
AZ signs monster obesity deal
The British giant has signed a deal with Chinese CSPC worth up to $18 billion, giving access to early-stage monthly injectables
3 February
Sandoz cracks blockbuster market
First competitor stepping into the top-earning space reveals the next steps to ensure uptake of the PBS-listed biosimilar
3 February
Best managed pharmas crowned
A ranking of companies by corporate effectiveness has revealed the pharmas that were best managed in 2025, amid a strong showing
2 February
Milestone PBAC victory finally lands
After a decade of wrangling, MSD has finally received a recommendation for its blockbuster drug Keytruda for multiple cancers
2 February
PBS spending hits 25-year low
Pfizer's pre-budget submission lifts the lid on practices used by the Govt that have pushed medicine funding into decline
2 February
Next-gen blockbuster hits PBS
With the first biosimilar of Bayer's Eylea also among a handful of the new additions to the scheme this month
2 February New to the PBS
TGA tick sets up PBAC win
Drug deferred by the PBAC last year pending TGA approval plus Seqirus buffs up Ferinject franchise with a new brand
2 February Approvals Action
And again: Aussie MD departs
The third ANZ Country Head departure this month has been announced with this leader promoted to a global role in the US
30 January
Next blockbuster wave looms
Find out which drugs are about to start their blockbuster run transforming treatment paradigms and passing US$1B in sales
30 January
Ex-Aussie GM's golden career run
ICYMI: Former Country Leader promoted, doubling his leadership territory plus the other most popular stories this week
30 January Your Week in 5 Minutes
PiF Advertise
PiF Advertise
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.